About VaxTrials
VaxTrials is a Healthcare company based in Panama City (Panama) founded in 2012, and was acquired by Emmes in October 2023. Vaccine clinical trials are managed and monitored by VaxTrials. Its chief executive, as recorded, is Jose Jimeno. VaxTrials offers products and services including Clinical Trial Management, Patient Recruitment Services, and Quality Assurance Framework. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its legal entity is VaxTRIALS, S. de R.L.
Company details
VaxTrials was founded in 2012 and is headquartered in Panama, Panama. Vaccine clinical trials are managed and monitored by this clinical research organization. Services include project management and feasibility assessments for such trials. Operations focus on the healthcare sector, supporting vaccine development. It was recently acquired by Emmes, a global CRO committed to public health initiatives.
- Headquarters Panama City, Panama
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website vaxtrials.com
- Social LinkedIn X
- Acquired by Emmes (Oct 2023)
- Legal Name Vaxtrials, S. De R.L.
Products & Services of VaxTrials
VaxTrials offers a comprehensive portfolio of products and services, including Clinical Trial Management, Patient Recruitment Services, and Quality Assurance Framework.
End-to-end oversight of clinical studies for vaccines
Data-driven planning and enrollment for clinical trial participants
Ensures high standards in clinical trial processes
Investors in VaxTrials
VaxTrials has secured backing from 1 investor. Prominent investors backing the company include Emmes.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Outsourced contract research organization services are provided to clients. | 1977 | emmes.com | United States |
Investor details for VaxTrials
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of VaxTrials
1 people are tracked at VaxTrials (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jose Jimeno | CEO | Leadership |
Complete people profiles for VaxTrials
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of VaxTrials
2 dated milestones of VaxTrials across 11 years, from founding to its latest funding, stage changes and deals.
- Founded VaxTrials is founded.
- Exit Acquired by Emmes.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vaxtrials
Complete news archive for VaxTrials
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VaxTrials
VaxTrials was founded in 2012.
VaxTrials is headquartered in Panama City, Panama.
Jose Jimeno is the CEO of VaxTrials, as recorded in our data.
VaxTrials was founded in 2012 and is headquartered in Panama, Panama. Vaccine clinical trials are managed and monitored by this clinical research organization. Services include project management and feasibility assessments for such trials. Operations focus on the healthcare sector, supporting vaccine development. It was recently acquired by Emmes, a global CRO committed to public health initiatives.
VaxTrials offers Clinical Trial Management, Patient Recruitment Services, and Quality Assurance Framework.
VaxTrials has 1 investor. Key investors include Emmes.
VaxTrials operates through Vaxtrials, S. De R.L..
Yes. VaxTrials was acquired by Emmes in October 2023.